Literature DB >> 18566375

An age-old paradigm challenged: old baboons generate vigorous humoral immune responses to LcrV, a plague antigen.

Sue Stacy1, Amanda Pasquali, Valerie L Sexton, Angelene M Cantwell, Ellen Kraig, Peter H Dube.   

Abstract

Immune senescence in the elderly results in decreased immunity with a concomitant increase in susceptibility to infection and diminished efficacy of vaccination. Nonhuman primate models have proven critical for testing of vaccines and therapeutics in the general population, but a model using old animals has not been established. Toward that end, immunity to LcrV, a protective Ag from Yersinia pestis, was tested in young and old baboons. Surprisingly, there was no age-associated loss in immune competence; LcrV elicited high-titer, protective Ab responses in the older individuals. The primary responses in the younger baboons were lower, but they did show boosting upon secondary immunization to the levels achieved in the old animals. The LcrV Ag was also tested in mice and, as expected, age-associated loss of immunity was seen; older animals responded with lower-titer Abs and, as a result, were more susceptible to Yersinia challenge. Thus, although age-related loss in immune function has been observed in humans, rodents, and some nonhuman primates, baboons appear to be unusual; they age without losing immune competence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566375      PMCID: PMC3663140          DOI: 10.4049/jimmunol.181.1.109

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity.

Authors:  S Romero-Steiner; D M Musher; M S Cetron; L B Pais; J E Groover; A E Fiore; B D Plikaytis; G M Carlone
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

2.  Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon.

Authors:  T Eto; H Takahashi
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

3.  Efficacy of anti-influenza peptide vaccine in aged mice.

Authors:  T Ben-Yedidia; L Abel; R Arnon; A Globerson
Journal:  Mech Ageing Dev       Date:  1998-08-01       Impact factor: 5.432

4.  Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case.

Authors:  K U Saikh; J Sesno; P Brandler; R G Ulrich
Journal:  Vaccine       Date:  1998 May-Jun       Impact factor: 3.641

Review 5.  Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans.

Authors:  Daniela Frasca; Richard L Riley; Bonnie B Blomberg
Journal:  Semin Immunol       Date:  2005-10       Impact factor: 11.130

6.  Insufficient protection for healthy elderly adults by tetanus and TBE vaccines.

Authors:  Ursula Hainz; Brigitte Jenewein; Esther Asch; Karl-P Pfeiffer; Peter Berger; Beatrix Grubeck-Loebenstein
Journal:  Vaccine       Date:  2005-05-09       Impact factor: 3.641

Review 7.  T cells in aging mice: genetic, developmental, and biochemical analyses.

Authors:  Richard A Miller; Scott B Berger; David T Burke; Andrzej Galecki; Gonzalo G Garcia; James M Harper; Amir A Sadighi Akha
Journal:  Immunol Rev       Date:  2005-06       Impact factor: 12.988

Review 8.  The effect of age on the cognate function of CD4+ T cells.

Authors:  Laura Haynes; Sheri M Eaton
Journal:  Immunol Rev       Date:  2005-06       Impact factor: 12.988

9.  Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Authors:  E D Williamson; H C Flick-Smith; C Lebutt; C A Rowland; S M Jones; E L Waters; R J Gwyther; J Miller; P J Packer; M Irving
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

10.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

View more
  19 in total

1.  Age-associated alteration in innate immune response in captive baboons.

Authors:  Dianne McFarlane; Roman F Wolf; Kristen A McDaniel; Gary L White
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-08-22       Impact factor: 6.053

2.  Enhancement of immune response to an antigen delivered by vaccinia virus by displaying the antigen on the surface of intracellular mature virion.

Authors:  Addie Embry; Xiangzhi Meng; Angelene Cantwell; Peter H Dube; Yan Xiang
Journal:  Vaccine       Date:  2011-06-12       Impact factor: 3.641

3.  Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.

Authors:  Weidong Zhang; Gul Ahmad; Workineh Torben; Zahid Noor; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; Maria Chavez-Suarez; Ronald B Podesta; Ronald C Kennedy; Afzal A Siddiqui
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

4.  A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.

Authors:  Jian Sha; Michelle L Kirtley; Curtis Klages; Tatiana E Erova; Maxim Telepnev; Duraisamy Ponnusamy; Eric C Fitts; Wallace B Baze; Satheesh K Sivasubramani; William S Lawrence; Igor Patrikeev; Jennifer E Peel; Jourdan A Andersson; Elena V Kozlova; Bethany L Tiner; Johnny W Peterson; David McWilliams; Snehal Patel; Eric Rothe; Vladimir L Motin; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

5.  Immune senescence in old and very old rhesus monkeys: reduced antibody response to influenza vaccination.

Authors:  Christopher L Coe; Gabriele R Lubach; Jeanne Kinnard
Journal:  Age (Dordr)       Date:  2012-01-10

Review 6.  Immune senescence in aged nonhuman primates.

Authors:  Kristen Haberthur; Flora Engelman; Alex Barron; Ilhem Messaoudi
Journal:  Exp Gerontol       Date:  2010-06-15       Impact factor: 4.032

7.  Protection against pneumonic plague following oral immunization with a non-replicating vaccine.

Authors:  Abby Jones; Catharine Bosio; Angela Duffy; Andrew Goodyear; Martin Schriefer; Steven Dow
Journal:  Vaccine       Date:  2010-06-19       Impact factor: 3.641

8.  Characterization of Baboon Cytomegalovirus Infection in Healthy Adult Baboons (Papio anubis).

Authors:  Erin L Willis; Taylor L Stevens; Gary L White; Dianne Mcfarlane
Journal:  Comp Med       Date:  2019-01-31       Impact factor: 0.982

Review 9.  Protecting against plague: towards a next-generation vaccine.

Authors:  E D Williamson; P C F Oyston
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

10.  Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Raymond T Damian; Roman F Wolf; Gary L White; Maria Chavez-Suarez; Ronald C Kennedy; Afzal A Siddiqui
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.